QIAGEN News | finanzen.ch

Kurse + Charts + Realtime		News + Analysen	Fundamental	Unternehmen	zugeh. Wertpapiere	Aktion
Kurs + Chart	Chart (gross)	News + Adhoc	Bilanz/GuV	Termine	Strukturierte Produkte	Portfolio
Times + Sales	Chartvergleich	Analysen	Schätzungen	Profil		Watchlist
Börsenplätze	Realtime Push	Kursziele	Dividende/GV
Historisch			Analysen

Kurse + Charts + Realtime

News + Analysen

Fundamental

Unternehmen

zugeh. Wertpapiere

Strukturierte Produkte

Aktion

Portfolio

Watchlist

06.05.20	QIAGEN Q1 Profit Tops Estimates - Quick Facts (RTTNews)
19.03.20	FDA Says No To Epilepsy Drug, IMV Advances COVID-19 Vaccine, ISEE Delays Study (RTTNews)
03.03.20	Stock Alert: Qiagen Climbs After Agreeing To Acquisition By Thermo Fisher (RTTNews)
03.03.20	Thermo Fisher To Buy Qiagen In $11.5 Bln Deal (RTTNews)
04.02.20	Qiagen Q4 Profit Down (RTTNews)
25.12.19	Qiagen Terminates Merger Talks; Plans To Execute Stand-alone Business Plan (RTTNews)
15.11.19	QIAGEN Receives Several Conditional, Non-binding Indications of Interest, and Decides to Enter Into Discussions to Explore Potential Strategic Alternatives (Businesswire)
15.11.19	QIAGEN erhält mehrere nicht verbindliche und unter Bedingungen stehende Interessensbekundungen und entscheidet, Gespräche über mögliche stra-tegische Alternativen zu führen (Businesswire)
14.11.19	Thermo Fisher Reportedly Considers To Buy Diagnostics Firm Qiagen (RTTNews)
05.11.19	QIAGEN Advances Its Portfolio Of Immuno-Oncology Assets - Quick Facts (RTTNews)
30.10.19	QIAGEN Updates 2019 Outlook - Quick Facts (RTTNews)
10.09.19	Qiagen To Integrate Global Sales Resources Into Business Areas (RTTNews)
29.08.19	DGAP-PVR: QIAGEN N.V.: Release according to Article 40, Section 1 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution (EQS Group)
29.08.19	DGAP-PVR: QIAGEN N.V.: Release according to Article 40, Section 1 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution (EQS Group)
29.08.19	DGAP-PVR: QIAGEN N.V.: Release according to Article 40, Section 1 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution (EQS Group)
29.08.19	DGAP-PVR: QIAGEN N.V.: Release according to Article 40, Section 1 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution (EQS Group)
22.08.19	DGAP-PVR: QIAGEN N.V.: Release according to Article 40, Section 1 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution (EQS Group)
13.08.19	DGAP-PVR: QIAGEN N.V.: Release according to Article 40, Section 1 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution (EQS Group)
06.08.19	DGAP-PVR: QIAGEN N.V.: Release according to Article 40, Section 1 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution (EQS Group)
06.08.19	DGAP-PVR: QIAGEN N.V.: Release according to Article 40, Section 1 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution (EQS Group)
01.08.19	DGAP-CMS: QIAGEN N.V.: Release of a capital market information (EQS Group)
30.07.19	QIAGEN Reports Updated 2019 Outlook - Quick Facts (RTTNews)
30.07.19	DGAP-PVR: QIAGEN N.V.: Release according to Article 40, Section 1 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution (EQS Group)
30.07.19	DGAP-PVR: QIAGEN N.V.: Release according to Article 40, Section 1 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution (EQS Group)
15.07.19	DGAP-PVR: QIAGEN N.V.: Release according to Article 40, Section 1 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution (EQS Group)
09.07.19	DGAP-PVR: QIAGEN N.V.: Release according to Article 40, Section 1 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution (EQS Group)
09.07.19	DGAP-PVR: QIAGEN N.V.: Release according to Article 40, Section 1 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution (EQS Group)
09.07.19	DGAP-PVR: QIAGEN N.V.: Release according to Article 40, Section 1 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution (EQS Group)
09.07.19	DGAP-PVR: QIAGEN N.V.: Release according to Article 40, Section 1 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution (EQS Group)
28.06.19	DGAP-PVR: QIAGEN N.V.: Release according to Article 40, Section 1 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution (EQS Group)
28.06.19	DGAP-PVR: QIAGEN N.V.: Release according to Article 40, Section 1 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution (EQS Group)
25.06.19	DGAP-PVR: QIAGEN N.V.: Release according to Article 40, Section 1 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution (EQS Group)
25.06.19	DGAP-PVR: QIAGEN N.V.: Release according to Article 40, Section 1 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution (EQS Group)
24.06.19	DGAP-CMS: QIAGEN N.V.: Veröffentlichung einer Kapitalmarktinformation (EQS Group)
24.06.19	DGAP-CMS: QIAGEN N.V.: Release of a capital market information (EQS Group)
18.06.19	DGAP-CMS: QIAGEN N.V.: Release of a capital market information (EQS Group)
18.06.19	DGAP-CMS: QIAGEN N.V.: Veröffentlichung einer Kapitalmarktinformation (EQS Group)
11.06.19	DGAP-CMS: QIAGEN N.V.: Release of a capital market information (EQS Group)
11.06.19	DGAP-CMS: QIAGEN N.V.: Veröffentlichung einer Kapitalmarktinformation (EQS Group)
04.06.19	DGAP-CMS: QIAGEN N.V.: Veröffentlichung einer Kapitalmarktinformation (EQS Group)
04.06.19	DGAP-CMS: QIAGEN N.V.: Release of a capital market information (EQS Group)
28.05.19	DGAP-CMS: QIAGEN N.V.: Veröffentlichung einer Kapitalmarktinformation (EQS Group)
24.05.19	DGAP-PVR: QIAGEN N.V.: Release according to Article 40, Section 1 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution (EQS Group)
21.05.19	DGAP-CMS: QIAGEN N.V.: Veröffentlichung einer Kapitalmarktinformation (EQS Group)
21.05.19	DGAP-CMS: QIAGEN N.V.: Release of a capital market information (EQS Group)
15.05.19	DGAP-CMS: QIAGEN N.V.: Veröffentlichung einer Kapitalmarktinformation (EQS Group)
15.05.19	DGAP-CMS: QIAGEN N.V.: Release of a capital market information (EQS Group)
13.05.19	DGAP-PVR: QIAGEN N.V.: Release according to Article 40, Section 1 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution (EQS Group)
08.05.19	DGAP-CMS: QIAGEN N.V.: Form 6-K for the quarterly period ended March 31, 2019 (EQS Group)
23.04.19	DGAP-AFR: Qiagen N.V.: Vorabbekanntmachung über die Veröffentlichung von Finanzberichten gemäss § 114, 115, 117 WpHG (EQS Group)

Newssuche

SMI
SPI
SLI
SMIM
DAX
ESTOXX
Dow Jones
S&P 500
NASDAQ 100
Nikkei 225

Logitech Intl	79.18	1.64 %	K V
CieFinRichemont	140.20	1.26 %	K V
Swiss Re	132.30	0.92 %	K V
Swiss Life Hldg	707.40	0.91 %	K V
Zurich Insur Gr	529.40	0.80 %	K V
Roche Hldg G	263.40	-0.57 %	K V
Kuehne+Nagel Int	200.00	-0.65 %	K V
Novartis	90.11	-0.75 %	K V
Givaudan	3’848.00	-0.95 %	K V
Lonza Grp	537.40	-1.29 %	K V

mehr

13.01.25		Synthetischer Aktienrückkauf: QIAGEN will Millionen an Aktionäre ausschütten - Aktie im Plus
08.01.25		QIAGEN verpartnert sich mit Genomics England - Aktie etwas schwächer
07.11.24		QIAGEN-Aktie springt hoch: QIAGEN überrascht positiv und hebt Gewinnprognose wieder an
11.10.24		QIAGEN-Aktie fällt: QIAGEN mit neuen Automationslösungen für Flüssigbiopsien
04.09.24		QIAGEN-Aktie schwächer: QIAGEN gibt finale Bedingungen für Wandelschuldverschreibungen bekannt
03.09.24		QIAGEN-Aktie verliert: QIAGEN startet Platzierung von Wandelschuldverschreibungen über 500 Millionen Dollar
12.06.24		QIAGEN-Aktie rot: 35 neue DNA-Nachweisverfahren für die Mikrobiomforschung: QIAGEN erweitert QIAcuity-Plattform
30.04.24		QIAGEN nach starken Zahlen auf Zielerreichungskurs - QIAGEN-Aktie dennoch knapp im Minus